Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Solara Active Pharma Sciences's Days Inventory or its related term are showing as below:
NSE:SOLARAPP1'
s Days Inventory Range Over the Past 10 Years
Min: 100.3 Med: 183.46 Max: 254.41
Current: 166.39
During the past 10 years, Solara Active Pharma Sciences's highest Days Inventory was 254.41. The lowest was 100.30. And the median was 183.46.
NSE:SOLARAPP1's Days Inventory is ranked worse than 55.92% of 921
companies
in the Drug Manufacturers industry
Industry Median: 164.48
vs NSE:SOLARAPP1: 166.39
Inventory Turnover measures how fast the company turns over its inventory within a year.
Solara Active Pharma Sciences's Inventory Turnover for the
three
months ended in Jun. 2026 was 0.62.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Solara Active Pharma Sciences's Inventory-to-Revenue for the
three
months ended in Jun. 2026 was 0.83.
Solara Active Pharma Sciences (NSE:SOLARAPP1) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Solara Active Pharma Sciences's Inventory Turnover for the
three
months ended in Jun. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Solara Active Pharma Sciences's Inventory to Revenue for the
three
months ended in Jun. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Solara Active Pharma Sciences Days Inventory Related Terms
Solara Active Pharma Sciences Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Solara Active Pharma Sciences Days Inventory Chart
NSE:SOLARAPP1 vs ZTS, UTHR: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Solara Active Pharma Sciences's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Solara Active Pharma Sciences Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Solara Active Pharma Sciences's Days Inventory distribution charts can be found below:
* The bar in red indicates where Solara Active Pharma Sciences's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Solara Active Pharma Sciences (NSE:SOLARAPP1) has a Days Inventory of 147.66 as of Jun. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Solara Active Pharma Sciences and its competitors. This is 20% below median its historical median of 183.46. Over the past decade, Solara Active Pharma Sciences' Days Inventory has ranged from 100.30 to 254.41. According to the industry distribution chart, Solara Active Pharma Sciences ranks #515 out of 921 companies in the Drug Manufacturers industry, placing it in the top 55.9%.
Is Solara Active Pharma Sciences' Days Inventory too high?
Solara Active Pharma Sciences' current Days Inventory of 147.66 is 20% below median its 10-year median of 183.46. Over the past 10 years, this metric has ranged from a low of 100.30 to a high of 254.41. The Drug Manufacturers industry median Days Inventory is 164.48. Solara Active Pharma Sciences' value of 147.66 is 10.2% below this industry median. Based on the distribution chart, Solara Active Pharma Sciences ranks #515 out of 921 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Solara Active Pharma Sciences has a GF Score™ of 68/100, reflecting its overall financial health beyond just this single metric.
How does Solara Active Pharma Sciences' Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Solara Active Pharma Sciences ranks #515 out of 921 companies for Days Inventory. This places Solara Active Pharma Sciences in the lower half of its industry. The industry median Days Inventory is 164.48. Solara Active Pharma Sciences' value of 147.66 is 10.2% below this benchmark. Historically, Solara Active Pharma Sciences' own Days Inventory has ranged from 100.30 to 254.41 over the past decade. While the company's 10-year median is 183.46 vs. the industry median of 164.48, Solara Active Pharma Sciences has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.48, based on 921 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Solara Active Pharma Sciences's current Days Inventory of 147.66 is 10.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Solara Active Pharma Sciences and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Solara Active Pharma Sciences's current Days Inventory is 147.66, which is 20% below median its own 10-year median of 183.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Solara Active Pharma Sciences stock overvalued right now?
Solara Active Pharma Sciences (NSE:SOLARAPP1) has a current Days Inventory of 147.66. The stock's GF Value™ is ₹308.01, compared to a current price of ₹267.45 — trading 13.2% below its estimated fair value. The current Days Inventory is 147.66, which is 20% below median its 10-year median of 183.46 and 10.2% below the Drug Manufacturers industry median of 164.48. Solara Active Pharma Sciences' overall GF Score™ is 68/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Solara Active Pharma Sciences (NSE:SOLARAPP1), the current Days Inventory is 147.66 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Solara Active Pharma Sciences (NSE:SOLARAPP1) Overvalued in 2026?
Based on GuruFocus' analysis, Solara Active Pharma Sciences stock appears to be undervalued.
The current stock price of ₹267.45 is trading 13.2% below its estimated GF Value™ of ₹308.01.
Key valuation signals for NSE:SOLARAPP1:
Days Inventory: 147.66 (20% below median its 10-year median of 183.46)
GF Value™: ₹308.01 vs. price of ₹267.45 (13.2% below fair value)
Industry Position: 10.2% below the Drug Manufacturers median (#515 of 921)
No single metric tells the full story. See the NSE:SOLARAPP1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Solara Active Pharma Sciences Business Description
Solara Active Pharma Sciences Ltd is engaged in the Active Pharmaceutical Ingredients (API) in India. It manufactures and develops APIs and offers services, including CRAMS and contract manufacturing for APIs. The company offers products and services, such as Anaesthetic, Analgesics, Antiviral, Retinoid, Anti-emetic, Antimalarial, Diuretic, Muscle relaxant, Antiallergics, Antihypertensive, Calcimimetic agent, Anti-seizure, Antigout, Cardiovascular, Anti-infective, Cough suppressant, and others. It also offers contract services, including contract development and manufacturing, and analytical services. Geographically, the company generates all of its revenue from India.
68GF Score
Get the complete analysis for NSE:SOLARAPP1
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SOLARAPP1 has been successfully added to your 
